Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More | Fox Lake Towing and Recovery

Home
Towing

Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More

by Melly Alazraki on Dec.20, 2010, under Towing

The U.S. biotech is holding an analyst and investor meeting focused on the commercial potential of its multiple sclerosis drug Campath. The goal: to convince Paris-based Sanofi-Aventis to raise its hostile takeover offer in a battle that has now gone on for five months.

Continue reading Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More

Genzyme Tries to Convince Sanofi-Aventis Its MS Drug Is Worth More originally appeared on DailyFinance on Mon, 20 Dec 2010 10:50:00.

Filed Under: Company News, Genzyme Corporation , Sanofi Aventis, Stocks in the News

:@aoloriginal, alemtuzumab, bid, biotech, biotech stocks, biotechnology, campath, cancer, Company News, contingent value rights, GENZ, GENZ, SNY, genzyme, Genzyme Corporation, Hostile Takeover, mergers and acquisitions, pharmaceuticals, price per share, sanofi-aventis, SNY, Stocks in the News, Takeover

Leave a Reply

You must be logged in to post a comment.

RSS feed for this post (comments) TrackBack URI

You Can Reach Us At:
For All Of Your Towing and Recovery Needs.
Tele: (847) 587-6076
Fax: (847) 587-8610
Search
Some Of Our Pics
Navigation
Recent Posts

Categories
- Towing

Recent Comments

Looking for something?

Use the form below to search the site:

Still not finding what you're looking for? Drop a comment on a post or contact us so we can take care of it!

Blogroll

A few highly recommended websites...

Archives

All entries, chronologically...